Palliative radiation therapy practice in patients with metastatic non-small-cell lung cancer: A cancer care outcomes research and surveillance consortium (CanCORS) study

Journal of Clinical Oncology

Volumn 31, Issue 5, 2013, Pages 558-564

  Chen, Aileen B ^a   Cronin, Angel ^a   Weeks, Jane C ^a   Chrischilles, Elizabeth A ^b   Malin, Jennifer ^c   Hayman, James A ^d   Schrag, Deborah ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; FEMALE; GROUPS BY AGE; HUMAN; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; LUNG SURGERY; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION;

ADULT; AGED; BONE NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; COHORT STUDIES; DOSE FRACTIONATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; OUTCOME ASSESSMENT (HEALTH CARE); PALLIATIVE CARE; PHYSICIAN'S PRACTICE PATTERNS; QUALITY OF LIFE; RADIOTHERAPY DOSAGE; TREATMENT OUTCOME; UNITED STATES;

EID: 84875408868     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.43.7954     Document Type: Article

References (42)

1. Edge SB, American Joint Committee on Cancer, American Cancer Society: AJCC Cancer Staging Handbook: From the AJCC Cancer Staging Manual (ed 7). New York, NY, Springer, 2010 http://www.springer.com/medicine/surgery/book/978-0- 387-88442-4
2. Jemal A, Siegel R, Xu J, et al: Cancer statistics, 2010. CA Cancer J Clin 60:277-300, 2010
3. Schiller JH, Harrington D, Belani CP, et al: Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 346:92-98, 2002 (Pubitemid 34438899)
4. Konski A, James J, Hartsell W, et al: Economic analysis of radiation therapy oncology group 97-14: Multiple versus single fraction radiation treatment of patients with bone metastases. Am J Clin Oncol 32:423-428, 2009
5. [No authors listed]: 8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: Randomised comparison with a multifraction schedule over 12 months of patient follow-up -Bone Pain Trial Working Party. Radiother Oncol 52:111-121, 1999
6. Hartsell WF, Scott CB, Bruner DW, et al: Randomized trial of short-versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst 97:798-804, 2005 (Pubitemid 40909122)
7. Steenland E, Leer JW, van Houwelingen H, et al: The effect of a single fraction compared to multiple fractions on painful bone metastases: A global analysis of the Dutch Bone Metastasis Study. Radiother Oncol 52:101-109, 1999 (Pubitemid 29461077)
8. Chow E, Harris K, Fan G, et al: Palliative radiotherapy trials for bone metastases: A systematic review. J Clin Oncol 25:1423-1436, 2007 (Pubitemid 46706892)
9. Wu JS, Wong R, Johnston M, et al: Metaanalysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys 55:594-605, 2003 (Pubitemid 36170000)
10. Sze WM, Shelley MD, Held I, et al: Palliation of metastatic bone pain: Single fraction versus multifraction radiotherapy -A systematic review of randomised trials. Clin Oncol (R Coll Radiol) 15:345-352, 2003 (Pubitemid 37069647)
11. Macbeth FR, Bolger JJ, Hopwood P, et al: Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status: Medical Research Council Lung Cancer Working Party. Clin Oncol (R Coll Radiol) 8:167-175, 1996 (Pubitemid 26248531)
12. Sundstrøm S, Bremnes R, Aasebø U, et al: Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: A national phase III trial. J Clin Oncol 22:801-810, 2004 (Pubitemid 41103591)
13. Fairchild A, Harris K, Barnes E, et al: Palliative thoracic radiotherapy for lung cancer: A systematic review. J Clin Oncol 26:4001-4011, 2008
14. Toy E, Macbeth F, Coles B, et al: Palliative thoracic radiotherapy for non-small-cell lung cancer: A systematic review. Am J Clin Oncol 26:112-120, 2003 (Pubitemid 36452296)
15. Lester JF, Macbeth FR, Toy E, et al: Palliative radiotherapy regimens for non-small cell lung cancer. Cochrane Database Syst Rev 4:CD002143, 2006
16. Fairchild A, Barnes E, Ghosh S, et al: International patterns of practice in palliative radiotherapy for painful bone metastases: Evidence-based practice? Int J Radiat Oncol Biol Phys 75:1501-1510, 2009
17. Ayanian JZ, Chrischilles EA, Fletcher RH, et al: Understanding cancer treatment and outcomes: The Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol 22:2992-2996, 2004
18. Malin JL, Ko C, Ayanian JZ, et al: Understanding cancer patients' experience and outcomes: Development and pilot study of the Cancer Care Outcomes Research and Surveillance patient survey. Support Care Cancer 14:837-848, 2006 (Pubitemid 44063448)
19. Catalano PJ, Ayanian JZ, Weeks JC, et al: Representativeness of Participants in the Cancer Care Outcomes Research and Surveillance Consortium Relative to the Surveillance, Epidemiology, and End Results Program. Med Care [epub ahead of print on March 7, 2012]
20. Piccirillo JF, Tierney RM, Costas I, et al: Prognostic importance of comorbidity in a hospitalbased cancer registry. JAMA 291:2441-2447, 2004 (Pubitemid 38669187)
21. Piccirillo JF, Costas I, Claybour P, et al: The measurement of comorbidity by cancer registries. J Regist Manage 30:8-14, 2003
22. He Y, Zaslavsky AM, Landrum MB, et al: Multiple imputation in a large-scale complex survey: A practical guide. Stat Methods Med Res 19:653-670, 2010
23. He Y: Missing data analysis using multiple imputation: Getting to the heart of the matter. Circ Cardiovasc Qual Outcomes 3:98-105, 2010
24. Hayman JA, Abrahamse PH, Lakhani I, et al: Use of palliative radiotherapy among patients with metastatic non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 69:1001-1007, 2007 (Pubitemid 47625852)
25. Fry WA, Phillips JL, Menck HR: Ten-year survey of lung cancer treatment and survival in hospitals in the United States: A national cancer data base report. Cancer 86:1867-1876, 1999 (Pubitemid 29513058)
26. Potosky AL, Saxman S, Wallace RB, et al: Population variations in the initial treatment of nonsmall-cell lung cancer. J Clin Oncol 22:3261-3268, 2004 (Pubitemid 41103681)
27. Bradley NM, Husted J, Sey MS, et al: Review of patterns of practice and patients' preferences in the treatment of bone metastases with palliative radiotherapy. Support Care Cancer 15:373-385, 2007 (Pubitemid 46697015)
28. Nestle U, Nieder C, Walter K, et al: A palliative accelerated irradiation regimen for advanced nonsmall-cell lung cancer vs. conventionally fractionated 60 GY: Results of a randomized equivalence study. Int J Radiat Oncol Biol Phys 48:95-103, 2000 (Pubitemid 30488218)
29. Glare P, Virik K, Jones M, et al: A systematic review of physicians' survival predictions in terminally ill cancer patients. BMJ 327:195-198, 2003 (Pubitemid 36920584)
30. Gripp S, Moeller S, Bölke E, et al: Survival prediction in terminally ill cancer patients by clinical estimates, laboratory tests, and self-rated anxiety and depression. J Clin Oncol 25:3313-3320, 2007 (Pubitemid 47325618)
31. Timmermans LM, van der Maazen RW, Leer JW, et al: Palliative or curative treatment intent affects communication in radiation therapy consultations. Psychooncology 15:713-725, 2006 (Pubitemid 44251664)
32. Lamont EB, Christakis NA: Prognostic disclosure to patients with cancer near the end of life. Ann Intern Med 134:1096-1105, 2001
33. Shakespeare TP, Lu JJ, Back MF, et al: Patient preference for radiotherapy fractionation schedule in the palliation of painful bone metastases. J Clin Oncol 21:2156-2162, 2003 (Pubitemid 46606364)
34. Barton MB, Dawson R, Jacob S, et al: Palliative radiotherapy of bone metastases: An evaluation of outcome measures. J Eval Clin Pract 7:47-64, 2001 (Pubitemid 32162578)
35. Szumacher E, Llewellyn-Thomas H, Franssen E, et al: Treatment of bone metastases with palliative radiotherapy: Patients' treatment preferences. Int J Radiat Oncol Biol Phys 61:1473-1481, 2005 (Pubitemid 40470431)
36. Lievens Y, Van den Bogaert W, Rijnders A, et al: Palliative radiotherapy practice within Western European countries: Impact of the radiotherapy financing system? Radiother Oncol 56:289-295, 2000
37. Jacobson M, O'Malley AJ, Earle CC, et al: Does reimbursement influence chemotherapy treatment for cancer patients? Health Aff (Millwood) 25:437-443, 2006 (Pubitemid 43529552)
38. Rodrigues G, Videtic GM, Sur R, et al: Palliative thoracic radiotherapy in lung cancer: An American Society for Radiation Oncology evidence-based clinical practice guideline. Pract Radiat Oncol 1:60-71, 2011
39. Lutz S, Berk L, Chang E, et al: Palliative radiotherapy for bone metastases: An ASTRO evidence-based guideline. Int J Radiat Oncol Biol Phys 79:965-976, 2011
40. American College of Radiology Appropriateness Criteria: Bone metastases. http://www.acr.org/Quality-Safety/Appropriateness-Criteria/Oncology/ Bone-Metastases
41. Janjan N, Lutz ST, Bedwinek JM, et al: Therapeutic guidelines for the treatment of bone metastasis: A report from the American College of Radiology Appropriateness Criteria Expert Panel on Radiation Oncology. J Palliat Med 12:417-426, 2009
42. National Comprehensive Cancer Network: Clinical Practice Guidelines: Non-Small Cell Lung Cancer (v.2.2010). http://www.nccn.org